Category: Treatments

Rituximab shows second-line promise in autoimmune limbic encephalitis

“Rituximab is effective and safe as a second-line immunotherapy for autoimmune limbic encephalitis, regardless of autoantibody status. Additional monthly rituximab therapy might potentiate the efficacy of rituximab,” concludes the authors of this Rituximab study published in medical journal, Neurology.  Lucy Piper of News Medical, an online, open-access medical information provider has published the article”Rituximab shows second-line promise in …

Read more

Dr. Luca Bartolini’s podcast on anti-NMDA receptor encephalitis

The following information was provided by Neurology, the official journal of the American Academy of Neurology. Dr. Luca Bartolini is interviewed about his survey in Neurology on how to treat anti-NMDA receptor encephalitis. The goal of the survey is to better understand best practices in treating this disease. The podcast can be found at Neurology® Clinical Practice …

Read more